TNFSF11 and periodontitis: Currently, many treatments for periodontitis target osteoclasts (e.g., estrogen replacement, bisphosphonates, and anti-RANKL antibodies), but these approaches are associated with adverse effects such as atypical fractures, delayed healing, heart attacks, and osteonecrosis of the jaw (28, 29, 30).